c-Jun NH2-terminal kinase (JNK)1 and jnk2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity

Journal of Experimental Medicine

Volumn 195, Issue 7, 2002, Pages 801-810

  Arbour, Nathalie ^a   Naniche, Denise ^a   Homann, Dirk ^a   Davis, Roger J ^b   Flavell, Richard A ^c   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular activation; Lymphocytic choriomeningitis virus; Protein kinases; T lymphocytes; Viral infection

Indexed keywords

GAMMA INTERFERON; PEPTIDE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; VIRUSES;

EID: 0036535149     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011481     Document Type: Article

References (57)

1. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
2. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development
3. Mammalian MAP kinase signalling cascades
4. c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1
5. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway
6. Selective interaction of JNK protein kinase isoforms with transcription factors
7. Defective T cell differentiation in the absence of Jnk1
8. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2
9. JNK1 is required for T cell-mediated immunity against Leishmania major infection
10. + T cell activation
11. Immunocytotherapy
12. Antigen-specific regulation of T cell-mediated cytokine production
13. Costimulation in antiviral immunity: Differential requirements for CD4(+) and CD8(+) T cell responses
14. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: Clearance of virus in vivo
15. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection
16. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response
17. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
18. + T cells during an acute virus infection
19. + T-cell memory
20. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus
21. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections
22. Cytotoxic T-cell memory without antigen
23. CD8 T cell memory in B cell-deficient mice
24. Lymphotoxin-beta-deficient mice show defective antiviral immunity
25. + CTL response
26. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection
27. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections
28. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
29. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
30. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses
31. Antiviral immune responses in CTLA4 transgenic mice
32. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide comptexes
33. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains
34. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-)
35. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice
36. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
37. Immune function in mice lacking the perforin gene
38. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: Role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains
39. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule
40. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation
41. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system
42. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection
43. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
44. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression
45. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence
46. High frequency of virus-specific interleukin-2-producing CD4(+) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection
47. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
48. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation
49. JNK is involved in signal integration during costimulation of T lymphocytes
50. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes
51. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation
52. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70
53. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF3, and NF-kappaB-inducing kinase
54. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule
55. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB
56. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
57. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal